Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea · Delayed Price · Currency is KRW 68,900
+300 (0.44%)
Jul 27, 2026, 1:49 PM KST
KRX:185750 Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,739,214 | 1,692,404 | 1,586,431 | 1,669,404 | 1,488,345 | 1,343,559 |
Revenue Growth | 6.97% | 6.68% | -4.97% | 12.16% | 10.78% | 3.11% |
Gross Profit Gross Profit Growth | 526,964 | 526,378 | 532,611 | 662,202 | 542,639 | 495,818 |
Operating Income Operating Income Growth | 82,202 | 80,568 | 99,462 | 246,599 | 109,906 | 94,759 |
Net Income Net Income Growth | 78,547 | 77,509 | 109,073 | 212,521 | 80,953 | 42,720 |
Earnings Per Share EPS Growth | 5923.89 | 5845.54 | 8234.00 | 15210.37 | 6013.65 | 3117.38 |
EPS Growth | -17.81% | -29.01% | -45.87% | 152.93% | 92.91% | -53.03% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 1,669,165 | 1,622,995 | 1,512,219 | 1,493,073 | 1,423,245 | 1,286,052 |
Others Others Growth | 18,468 | 19,230 | 35,405 | 133,980 | 19,208 | 7,340 |
Japan Japan Growth | 43,502 | 43,135 | 38,197 | 41,157 | 45,891 | 43,913 |
Swiss Swiss Growth | - | 7,044 | 610.64 | - | - | - |
Total Total Growth | 1,739,214 | 1,692,404 | 1,586,431 | 1,669,404 | 1,488,345 | 1,343,559 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 285,226 | 346,503 | 302,171 | 365,065 | 155,861 | 187,333 |
Total Debt Total Debt Growth | 368,005 | 367,758 | 188,152 | 219,764 | 235,738 | 237,054 |
Net Cash (Debt) Net Cash Growth | -82,778 | -21,255 | 114,018 | 145,301 | -79,877 | -49,721 |
Net Cash Growth | - | - | -21.53% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -6218.34 | -1596.60 | 8607.82 | 10399.38 | -5933.68 | -3628.24 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 85,931 | 67,359 | 64,289 | 318,160 | 67,734 | 12,904 |
Capital Expenditures CapEx Growth | -194,935 | -140,917 | -38,474 | -41,218 | -44,898 | -48,243 |
Free Cash Flow Free Cash Flow Growth | -109,004 | -73,558 | 25,815 | 276,942 | 22,836 | -35,339 |
Free Cash Flow Growth | - | - | -90.68% | 1112.74% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 30.30% | 31.10% | 33.57% | 39.67% | 36.46% | 36.90% |
Operating Margin | 4.73% | 4.76% | 6.27% | 14.77% | 7.38% | 7.05% |
Pretax Margin | 4.70% | 4.82% | 6.43% | 14.47% | 6.53% | 6.00% |
Profit Margin | 4.52% | 4.58% | 6.88% | 12.73% | 5.44% | 3.18% |
FCF Margin | -6.27% | -4.35% | 1.63% | 16.59% | 1.53% | -2.63% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.58 | 14.09 | 10.81 | 7.84 | 12.38 | 30.72 |
Forward PE | 13.86 | 14.47 | 14.47 | 18.84 | 14.29 | 14.96 |
P/FCF Ratio | - | - | 45.67 | 6.02 | 43.87 | - |
PS Ratio | 0.52 | 0.65 | 0.74 | 1.00 | 0.67 | 0.98 |